New antifungal agents-treatment standards are beginning to grow old.
Maschmeyer
Georg
G
Charité University Hospital, Campus Virchow-Klinikum, Department of Haematology and Oncology, Augustenburger Platz 1, D-13353 Berlin, Germany. georg.maschmeyer@charite.de
D000666:Amphotericin B / Q000191:economics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D000077336:Caspofungin; D054714:Echinocandins; D006801:Humans; D017964:Itraconazole / Q000191:economics / Q000627:therapeutic use; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D017410:Practice Guidelines as Topic / Q000592:standards*
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D017964:Itraconazole; D000666:Amphotericin B; D000077336:Caspofungin